ClariVest Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$1.41M Hold
16,768
0.14% 194
2024
Q2
$1.41M Buy
16,768
+6
+0% +$506 0.14% 194
2024
Q1
$1.23M Sell
16,762
-83
-0.5% -$6.07K 0.13% 230
2023
Q4
$1.2M Sell
16,845
-1,010
-6% -$72.1K 0.07% 216
2023
Q3
$1.07M Buy
17,855
+5
+0% +$299 0.06% 227
2023
Q2
$1.29M Sell
17,850
-2,690
-13% -$194K 0.06% 194
2023
Q1
$1.51M Buy
20,540
+7
+0% +$515 0.07% 212
2022
Q4
$1.37M Sell
20,533
-12,486
-38% -$834K 0.07% 229
2022
Q3
$1.77M Buy
33,019
+32,977
+78,517% +$1.77M 0.09% 175
2022
Q2
$2K Buy
+42
New +$2K ﹤0.01% 556
2019
Q4
Sell
-32,365
Closed -$2.01M 683
2019
Q3
$2.01M Sell
32,365
-15,549
-32% -$965K 0.05% 258
2019
Q2
$3.41M Sell
47,914
-320
-0.7% -$22.8K 0.08% 196
2019
Q1
$3.78M Sell
48,234
-2,418
-5% -$190K 0.08% 217
2018
Q4
$4.29M Buy
50,652
+13,381
+36% +$1.13M 0.09% 192
2018
Q3
$6.38M Buy
37,271
+1,744
+5% +$299K 0.11% 135
2018
Q2
$4.59M Buy
35,527
+21,637
+156% +$2.8M 0.08% 206
2018
Q1
$1.43M Buy
13,890
+160
+1% +$16.5K 0.02% 378
2017
Q4
$1.17M Buy
+13,730
New +$1.17M 0.02% 407
2017
Q1
Sell
-29,545
Closed -$1.87M 719
2016
Q4
$1.87M Sell
29,545
-29
-0.1% -$1.84K 0.05% 274
2016
Q3
$1.88M Hold
29,574
0.05% 227
2016
Q2
$2.2M Buy
29,574
+4,008
+16% +$298K 0.07% 189
2016
Q1
$1.71M Buy
25,566
+986
+4% +$65.9K 0.05% 219
2015
Q4
$1.66M Sell
24,580
-513
-2% -$34.7K 0.05% 213
2015
Q3
$1.34M Sell
25,093
-642
-2% -$34.3K 0.04% 232
2015
Q2
$1.62M Buy
+25,735
New +$1.62M 0.05% 230
2014
Q1
Sell
-194
Closed -$6K 627
2013
Q4
$6K Sell
194
-133
-41% -$4.11K ﹤0.01% 522
2013
Q3
$9K Hold
327
﹤0.01% 474
2013
Q2
$8K Buy
+327
New +$8K ﹤0.01% 447